Yangzhou, November 17, 2023/PRNewswire/ -- Meihua International Medical Technology Co., Ltd. (“MHUA” or “Company”) (NASDAQ: MHUA), a reputable manufacturer and supplier of Class 1, 2, and 3 disposable medical devices with operating subsidiaries in China, announced today that it will soon launch an innovative AI intelligent warehouse management and medical device logistics platform, Speed Fox. The platform was developed by MHUA in collaboration with an outstanding team of leading higher education institutions in China (hereafter referred to as the “institution”). MHUA believes that Speed Fox represents the company's strategic initiatives aimed at broadening its business and revolutionizing the field of medical device logistics.
Under the banner of innovation, MHUA launched the Speed Fox program earlier this year, taking full advantage of the cutting-edge capabilities of ChatGPT tools. Working closely with the agency's team, MHUA has carefully created an advanced AI health service platform that aims to revolutionize warehouse management operations and enhance user interaction and experience.
MHUA believes that Speed Fox plays a key role in medical device logistics and warehousing management, streamlining operations and providing an unparalleled user experience. Within the warehouse, Speed Fox was designed as a virtual assistant to seamlessly manage inventory by updating inventory levels, tracking cargo shipments, and generating comprehensive reports in real time. Leveraging the power of ChatGPT's natural language processing, MHUA believes this intuitive interface will enable warehouse workers to seamlessly communicate with the system, issue instructions, check product availability, and receive automated alarms for restocking.
In addition to excellent operational performance, Speed Fox was also designed as an intelligent interface for customers and medical professionals. Users can easily obtain information on medical devices, track orders, and receive expert guidance on product usage. With advanced ChatGPT language understanding capabilities, MHUA believes the platform will ensure accurate responses to user queries, providing a seamless and personalized customer experience.
MHUA expects Speed Fox's adaptive ChatGPT learning capabilities will keep the platform at the cutting edge of the ever-evolving field of medical device logistics. MHUA believes this will also ensure that the information provided by Speed Fox is not only up to date, but also in line with industry standards.
Speed Fox is expected to expand its application scenarios by using historical data and user preferences to predict user needs. The platform is expected to provide personalized recommendations for medical devices, tailored to individual needs. MHUA believes this level of automation will optimize overall efficiency, reduce response times, and establish Speed Fox as an indispensable asset in medical device logistics.
“We believe Speed Fox will revolutionize the way companies manage medical device logistics,” said Mr. Liu Yongjun, Chairman of MHUA. By combining cutting-edge AI technology with our extensive expertise in medical devices, we aim to create a new era of efficiency, reliability, and customer satisfaction.”
“The company is pleased to announce that the first version of Speed Fox is scheduled to launch in mid-2024. “By broadening our business and entering AI-driven health services, MHUA aims to empower businesses across all industries and strengthen our leadership position in the industry.”
About Meihua International Medical Technology Co., Ltd.
Meihua International Medical Technologies Co., Ltd. (Meihua International Medical Technologies Co., Ltd.) It is a well-known manufacturer and supplier of Class I, Class II, and Class III disposable medical devices in China, and has operating subsidiaries in China. The company produces and sells Class I disposable medical consumables such as eye drop bottles, medicine bottles, artificial anal bags, etc., and identification wristbands, gynecological examination kits, surgical examination kits, surgical kits, medical brushes, medical dressings, masks, disposable infusion pumps, electronic pumps, puncture packs, etc., and acts as an agent for the distribution of disposable medical devices purchased from other manufacturers. The company has passed international “CE” certification and ISO 13485 system certification, and has registered more than 20 products with the US FDA (registration number: 3006554788). The company has served hospitals, pharmacies, medical institutions and medical equipment companies for more than 30 years. It sells more than 800 products domestically, and exports more than 120 products to more than 30 countries, covering Europe, North America, South America, Asia, Africa and Oceania. For more information, please visit:.
The statements in this press release relating to the Company's future expectations, plans and outlook constitute forward-looking statements as defined by the Private Securities Liability Reform Act of 1995. Forward-looking statements include factual statements about plans, goals, objectives, strategies, future events, expected performance, assumptions, and any other factual statement that has not already occurred. Any wording involving “possible,” “will,” “want,” “should,” “should,” “believe,” “expect,” “anticipate,” “estimate,” or similar unfactual language, particularly regarding the company's listing on the NASDAQ global market and completion of the launch, should be considered a forward-looking statement. Actual results may differ materially from historical results or from what is stated in these forward-looking statements, depending on various factors. These factors include, but are not limited to, the company's strategic goals, the company's future plans, market demand and user acceptance of the company's products or services, technology updates, economic trends, the company's reputation and brand, the impact of industry competition and bidding, relevant policies and regulations, the ups and downs of China's macroeconomic conditions, the international market conditions for the company's services, and the risks and related assumptions disclosed in the prospectus. In view of the above and other related reasons, we recommend investors not to blindly rely on these forward-looking statements, and we urge investors to visit the SEC website to check the company's relevant documents for other factors that may affect the company's future operating results. The company has no obligation to publicly revise changes to these forward-looking statements due to specific events or reasons after these documents have been declared.
Weiss Investor Relations Services, Inc.
Telephone: +86 13811768599